Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Ivermectin  COVID-19 treatment studies for Ivermectin  C19 studies: Ivermectin  Ivermectin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Interaction of the New Inhibitor Paxlovid (PF-07321332) and Ivermectin With the Monomer of the Main Protease SARS-CoV-2: A Volumetric Study Based on Molecular Dynamics, Elastic Networks, Classical Thermodynamics and SPT
Alvarado et al., Computational Biology and Chemistry, doi:10.1016/j.compbiolchem.2022.107692
Alvarado et al., Interaction of the New Inhibitor Paxlovid (PF-07321332) and Ivermectin With the Monomer of the Main Protease.., Computational Biology and Chemistry, doi:10.1016/j.compbiolchem.2022.107692
May 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
In Silico study comparing ivermectin and paxlovid Mpro interaction, showing similar interaction for paxlovid and the ivermectin B1a homologue, a different mechanism for ivermectin B1b, and interaction at different sites for paxlovid.
Alvarado et al., 14 May 2022, peer-reviewed, 12 authors.
Contact: alvaradoysaias@gmail.com, lgonzalezpaz@gmail.com.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperIvermectinAll
Abstract: Journal Pre-proof Interaction of the New Inhibitor Paxlovid (PF07321332) and Ivermectin With the Monomer of the Main Protease SARS-CoV-2: A Volumetric Study Based on Molecular Dynamics, Elastic Networks, Classical Thermodynamics and SPT Ysaias José Alvarado, Yosmari Olivarez, Carla Lossada, Joan Vera-Villalobos, José Luis Paz, Eddy Vera, Marcos Loroño, Alejandro Vivas, Fernando Javier Torres, Laura N. Jeffreys, María Laura Hurtado-León, Lenin González-Paz PII: S1476-9271(22)00072-X DOI: https://doi.org/10.1016/j.compbiolchem.2022.107692 Reference: CBAC107692 To appear in: Computational Biology and Chemistry Received date: 4 January 2022 Revised date: 28 April 2022 Accepted date: 2 May 2022 Please cite this article as: Ysaias José Alvarado, Yosmari Olivarez, Carla Lossada, Joan Vera-Villalobos, José Luis Paz, Eddy Vera, Marcos Loroño, Alejandro Vivas, Fernando Javier Torres, Laura N. Jeffreys, María Laura Hurtado-León and Lenin González-Paz, Interaction of the New Inhibitor Paxlovid (PF-07321332) and Ivermectin With the Monomer of the Main Protease SARS-CoV-2: A Volumetric Study Based on Molecular Dynamics, Elastic Networks, Classical Thermodynamics and SPT, Computational Biology and Chemistry, (2022) doi:https://doi.org/10.1016/j.compbiolchem.2022.107692 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2022 Published by Elsevier. Interaction of the new inhibitor Paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARSCoV-2: a volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT Ysaias José Alvaradoa*, Yosmari Olivarezb, Carla Lossadaa, Joan Vera-Villalobosc, José Luis Pazd, Eddy Verab, Marcos Loroñoe, Alejandro Vivasb, Fernando Javier Torresf,g , Instituto Venezolano de Investigaciones Científicas (IVIC). Centro de Investigación ro a of Laura N. Jeffreysh, María Laura Hurtado-Leóni, Lenin González-Pazj,i* y Tecnología de Materiales (CITeMA). Laboratorio de Caracterización Molecular y b -p Biomolecular. 4001 Maracaibo, Republica Bolivariana de Venezuela. Universidad del Zulia (LUZ). Facultad Experimental de Ciencias (FEC). re Departamento de Quimica. Laboratorio de Electronica Molecular. 4001 Maracaibo, Republica Bolivariana de Venezuela. Facultad de Ciencias Naturales y Matemáticas, Departamento de Química y Ciencias lP c Ambientales, Laboratorio de Análisis Químico Instrumental (LAQUINS), Escuela d rn a Superior Politécnica del Litoral, Guayaquil, Ecuador. Departamento Académico de Química Inorgánica, Facultad de Química e Ingeniería Química, Universidad Nacional Mayor de San Marcos. Lima, Perú. Departamento Académico de Química Analítica e Instrumental, Facultad de Química Jo u e e Ingeniería Química, Universidad Nacional Mayor de San Marcos. Lima, Perú. f Grupo de Química Computacional y Teórica (QCT-UR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia g Grupo de Química Computacional y..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit